GOETSCH LILIANE has a total of 31 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BIOSCEPTRE AUST PTY LTD, SYMPHOGEN A and BIOSCEPTRE INTERNATIONAL LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 31 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Goetsch Liliane | 31 |
#2 | Wurch Thierry | 11 |
#3 | Corvaia Nathalie | 10 |
#4 | Bes Cédric | 6 |
#5 | Haeuw Jean-Francois | 6 |
#6 | Bes Cedric | 6 |
#7 | Beck Alain | 4 |
#8 | Leger Olivier | 4 |
#9 | Jouhanneaud Alexandra | 3 |
#10 | Duflos Alain | 3 |
Publication | Filing date | Title |
---|---|---|
US2015291696A1 | Anti-cMET antibody | |
US2013084243A1 | Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders | |
US2013216527A1 | Novel anti-cmet antibody | |
US2011097262A1 | Anti-c-Met antibody | |
US2008193445A1 | Novel anti-IGF-IR antibodies and uses thereof |